Examining the impact of bone pathology on type I Gaucher disease-Reference-Cited by-同舟云学术

Examining the impact of bone pathology on type I Gaucher disease

Published:2014-02-01 Issue:1 Volume:9 Page:61-70
ISSN:1758-4299
Container-title:Clinical Lipidology
language:en
Short-container-title:Clinical Lipidology

Author:

Mucci Juan Marcos¹,Rozenfeld Paula Adriana¹

Affiliation:

1. LISIN, Departamento de Ciencias Biológicas, Facultad de Ciencias ExactasUniversidad Nacional de La Plata, 47 y 115 (1900) La Plata, Argentina

Publisher

Informa UK Limited

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism

Link

https://www.tandfonline.com/doi/pdf/10.2217/clp.13.78

Reference85 articles.

1. Grabowski GA, Beutler E. Gaucher disease. In: The Online Metabolic and Molecular Basis of Inherited Diseases. Scriver CR, Beaudet AL, Sly WS (Eds). McGraw‑Hill, NY, USA (2009).

2. Meikle PJ, Hopwood JJ, Clague AE et al. Prevalence of lysosomal storage disorders. JAMA 281, 249–254 (1999).

3. Barton NW, Brady RO, Dambrosia JM et al. Replacement therapy for inherited enzyme deficiency‑macrophage‑targeted glucocerebrosidase for Gaucher’s disease. N. Engl. J. Med. 324, 1464–1470 (1991).

4. Mistry P, Germain DP. Phenotype variations in Gaucher disease. Rev. Med. Intern. 27(Suppl. 1), S3–S10 (2006).

5. Wittmann J, Karg E, Turi S et al. Newborn screening for lysosomal storage disorders in hungary. JIMD Rep. 6, 117–125 (2012).

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Lipid Profile Assessment in Monitoring the effect of Imiglucerase in Children with Gaucher Disease;Research Journal of Pharmacy and Technology;2023-02-28

2. Gaucher disease – more than just a rare lipid storage disease;Journal of Molecular Medicine;2022-01-23